Filing Details
- Accession Number:
- 0001567619-19-023466
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-12-19 20:09:19
- Reporting Period:
- 2019-12-17
- Accepted Time:
- 2019-12-19 20:09:19
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1048477 | Biomarin Pharmaceutical Inc | BMRN | Pharmaceutical Preparations (2834) | 680397820 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1247681 | Bryan V Lawlis | C/O Biomarin Pharmaceutical Inc. 105 Digital Drive Novato CA 94949 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-12-17 | 3,750 | $21.51 | 27,340 | No | 4 | M | Direct | |
Common Stock | Disposition | 2019-12-17 | 3,750 | $83.36 | 23,590 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to buy Common Stock) | Disposition | 2019-12-17 | 3,750 | $0.00 | 3,750 | $21.51 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
3,750 | 2010-11-12 | 2020-05-11 | No | 4 | M | Direct |
Footnotes
- Trade made pursuant to a 10b5-1 plan executed on May 1, 2019.
- Reflects the number of options outstanding after the transactions from the specific stock option grant.